, Tracking Stock Market Picks
Enter Symbol:
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

down 72.02 %

Cubist Pharmaceuticals, Inc. (CBST) upgraded to Outperform with price target $76 by Leerink Swann

Posted on: Thursday,  Sep 26, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 09/26/2013. Previously Leerink Swann rated Underperform Cubist Pharmaceuticals, Inc. (NASDAQ: CBST)
on 02/11/2009., when the stock price was $18.75. Since then, Cubist Pharmaceuticals, Inc. has gained 257.49% as of 09/26/2013's recent price of $67.03.
If you would have followed the previous Leerink Swann 's recommendation on CBST, you would have lost 72.02% of your investment in 1688 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/26/2013 8:25 AM Buy
67.03 76.00
as of 12/13/2013
1 Week down  -3.62 %
1 Month up  0.36 %
3 Months down  -9.79 %
1 YTD down  -65.74 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2009 8:25 AM Sell
18.75 17.00
12/8/2008 8:25 AM Sell
25.73 21.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy